课题基金 / 基金详情

项目摘要

项目成果

Chris L KEPLEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Nanotechnology, the use of nanomaterials at the molecular level, is a multidisciplinary scientific field undergoing exponential growth and has broad applications among all divisions of science. One form of nanomaterials, fullerenes, is soccer-ball-shaped carbon cages that can be functionalized and derivatized with a wide array of molecules. Given their unique structure and properties, fullerenes are being investigated as a new and/or improved way to diagnose, monitor, and treat certain conditions. However, no studies have examined the effects these compounds have on the allergic response. Mast cells (MC) and peripheral blood basophils (PBB) are important effector cells that have traditionally been associated with initiating and propagating the allergic response. Recent studies suggest that these cells may also be important regulators of inflammation and innate immunity. We have discovered an unexpected and new mechanism through which the allergic process is inhibited using fullerenes. We hypothesize that fullerene nanomaterials may be a heretofore unrecognized, and potentially useful, way to inhibit diseases that are critically affected by MC and PBB responses. Further, we hypothesize these molecules may be manipulated in such a way that allows them to specifically target MC and PBB. To test these hypotheses we will use a combination of primary human MC and PBB in addition to murine models of human disease including allergy, arthritis, and multiple sclerosis. Our goal is to determine if fullerenes can inhibit the induction and progression of those diseases that have previously been shown to have a large MC/PBB influence. This completely novel research program may lay the foundation for new strategies not only for allergy treatment but for those diseases that are mediated by MC and PBB responses such as arthritis and autoimmune disease. Project Narrative: Allergic diseases, arthritis, multiple sclerosis, and other autoimmune diseases are huge public health problems that affect millions of Americans. These diseases are induced and propagated largely by mast cells and basophils. We have discovered that certain nanomaterials block their noxious effects and thus may be a new way to control those diseases that are largely mediated by these cells types.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/bc1001664
发表时间: 2010-09-15
期刊: BIOCONJUGATE CHEMISTRY
影响因子: 4.7
作者: [Zhou, Zhiguo, Lenk, Robert P., Dellinger, Anthony, Wilson, Stephen R., Sadler, Robert, Kepley, Christopher L.]
通讯作者: Kepley, Christopher L.
DOI: 10.1166/jbn.2010.1157
发表时间: 2010-10
期刊: Journal of biomedical nanotechnology
影响因子: 2.9
作者: [Zhiguo Zhou;S. Joslin;Anthony L. Dellinger;M. Ehrich;Brad Brooks;Q. Ren;U. Rodeck;R. Lenk;C. Kepley]
通讯作者: Zhiguo Zhou;S. Joslin;Anthony L. Dellinger;M. Ehrich;Brad Brooks;Q. Ren;U. Rodeck;R. Lenk;C. Kepley
DOI: 10.1186/1532-429x-15-7
发表时间: 2013-01-16
期刊: Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
影响因子: --
作者: [Dellinger A, Olson J, Link K, Vance S, Sandros MG, Yang J, Zhou Z, Kepley CL]
通讯作者: Kepley CL
Human mast cells as a platform for new cancer immunotherapy strategies
  • 批准号:
    10729728
  • 项目类别:
  • 资助金额:
    $37.28万
  • 财政年份:
    2023
  • 负责人:
    Chris L KEPLEY
  • 依托单位:
Studies examining quantitative in vivo imaging of breast cancer-targeted,therapeutic human mast cells
  • 批准号:
    10618003
  • 项目类别:
  • 资助金额:
    $19.04万
  • 财政年份:
    2022
  • 负责人:
    Chris L KEPLEY
  • 依托单位:
Studies examining quantitative in vivo imaging of breast cancer-targeted, therapeutic human mast cells
Prevention of Allergic Disease Using Nanomaterials
  • 批准号:
    7944097
  • 项目类别:
  • 资助金额:
    $26.33万
  • 财政年份:
    2009
  • 负责人:
    Chris L KEPLEY
  • 依托单位:
海外基金